Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2006-03-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10549-006-9181-4PMID 16541316
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer.

  2005cited by this paper
• Circulating tumor cells in adjuvant breast cancer patients

  2005cited by this paper
• Quantitative monitoring of circulating epithelial cells for individual therapy control in lung and breast cancer during neoadjuvant treatment, surgery and adjuvant chemotherapy

  2005cited by this paper
• Circulating tumor cells, disease progression, and survival in metastatic breast cancer.

  2004cited by this paper
• Circulating tumour cells in breast cancer.

  2004cited by this paper
• Enumeration of Circulating Tumor Cells in the Blood of Breast Cancer Patients After Filtration Enrichment: Correlation with Disease Stage

  2004cited by this paper
• Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases

  2004cited by this paper
• Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients

  2003cited by this paper
• Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance.

  2002cited by this paper
• Peripheral blood tumor cell load reflects the clinical activity of the disease in patients with carcinoma of the breast.

  2000cited by this paper
• Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction and immunocytochemical techniques.

  2000cited by this paper
• RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: correlation with established prognostic parameters

  2000cited by this paper
• Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood

  1995cited by this paper
• Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase‐polymerase chain reaction for tyrosine hydroxylase mRNA

  1995cited by this paper
• Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance.

  1995cited by this paper
• Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction.

  1994cited by this paper
• Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of delta and gamma T-cell receptor genes.

  1994cited by this paper
• Detection of neuroblastoma cells in blood.

  1990cited by this paper
• Failure of tetrachlorodecaoxygen anion complex to assist wound healing.

  1989cited by this paper
• Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification.

  1987cited by this paper
• Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody.

  1985cited by this paper
• Detection of micrometastases in patients with primary breast cancer.

  1983cited by this paper
• CANCER CELLS IN THE PERIPHERAL BLOOD: A SECOND LOOK.

  1965cited by this paper
• CANCER CELLS IN THE PERIPHERAL BLOOD: A SECOND LOOK.

  1965cited by this paper

• Primary tumor resection might improve outcomes in metastatic thoracic esophageal cancer

  2025cites this paper
• Redefining cancer care: harnessing circulating tumor cells’ potential for improved diagnosis and prognosis

  2025cites this paper
• Circulating tumor cells in solid malignancies: From advanced isolation technologies to biological understanding and clinical relevance in early diagnosis and prognosis.

  2024cites this paper
• Survival outcome and optimal candidates of primary tumor resection for patients with metastatic medullary thyroid cancer.

  2024cites this paper
• Efficacy of concurrent radiotherapy in patients with locally advanced rectal cancer and synchronous metastasis receiving systemic therapy

  2023cites this paper
• Surgical resection of primary tumors improves survival in patients with lung metastases: a population-based SEER analysis

  2023cites this paper
• Survival effects of primary and metastatic surgical treatment in metastatic small intestinal tumors: A propensity score–matching study

  2022cites this paper
• Survival benefit of primary tumor resection for gastric cancer with liver metastasis: A propensity score-matched, population-based study

  2022cites this paper
• Clinical Relevance and Therapeutic Application of CTCs in Advanced Breast Cancer.

  2020cites this paper
• The Lack of Evidence for an Association between Cancer Biomarker Conversion Patterns and CTC-Status in Patients with Metastatic Breast Cancer

  2020cites this paper
• Survival outcome of palliative primary tumor resection for colorectal cancer patients with synchronous liver and/or lung metastases: A retrospective cohort study in the SEER database by propensity score matching analysis.

  2020cites this paper
• Circulating Tumor Cells in Breast Cancer Metastatic Disease

  2020cites this paper
• Detection and prognostic relevance of circulating tumour cells (CTCs) in Asian breast cancers using a label-free microfluidic platform

  2019cites this paper
• Comparison of SUVmax Values Obtained from F-18 FDG PET/CT and Cell-free DNA Levels Measured from Plasma in Oncology Patients

  2019cites this paper
• Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first-line randomised trials from the ARCAD database.

  2018cites this paper
• Comparison of three different methods for the detection of circulating tumor cells in mice with lung metastasis

  2017cites this paper
• Simple and rapid colorimetric detection of melanoma circulating tumor cells using bifunctional magnetic nanoparticles.

  2017cites this paper
• Circulating Tumour Cells in Primary Disease: The Seed for Metastasis

  2017cites this paper
• Molecular characterization of circulating tumor cells-from bench to bedside.

  2017cites this paper
• Detecting Blood-Based Biomarkers in Metastatic Breast Cancer: A Systematic Review of Their Current Status and Clinical Utility

  2017cites this paper
• Profiling of circulating tumor cells in liquid biopsies from metastatic cancer patients

  2017cites this paper
• Improved Survival After Primary Tumor Surgery in Metastatic Breast Cancer: A Propensity-adjusted, Population-based SEER Trend Analysis

  2016cites this paper
• The potential for liquid biopsies in the precision medical treatment of breast cancer

  2016cites this paper
• Circulating tumor cell isolation: the assets of filtration methods with polycarbonate track-etched filters.

  2015cites this paper
• Circulating tumor cells isolation: the "post-EpCAM era".

  2015cites this paper
• The systematic study of circulating tumor cell isolation using lithographic microfilters.

  2014cites this paper
• Biological interfacial engineering for metastatic cancer diagnosis and intervention.

  2014cites this paper
• CTC enumeration and characterization: moving toward personalized medicine.

  2014cites this paper
• La performance diagnostique des marqueurs tumoraux messagers dans le diagnostic et le suivi du cancer du sein

  2014cites this paper
• Circulating Tumor Cells as Biomarkers

  2013cites this paper
• Detecting Circulating Tumor Cells: Current Challenges and New Trends

  2013influential citation
• Potential usefulness of CTC detection in follow up of prostate cancer patients. A preliminary report obtained by using Adnagene platform.

  2013cites this paper
• Relevance of molecular characterization of circulating tumor cells in breast cancer in the era of targeted therapies

  2013cites this paper
• Detection and prognostic significance of circulating tumor cells in nonmetastatic breast cancer patients

  2013cites this paper
• Meta-Analysis of the Prognostic Value of Circulating Tumor Cells in Breast Cancer

  2012cites this paper
• Clinical relevance of circulating CK-19mRNA-positive tumour cells before front-line treatment in patients with metastatic breast cancer

  2012influential citation
• Analysis of the specificity and selectivity of anti-EpCAM antibodies in breast cancer cell lines.

  2012cites this paper
• Dynamics of circulating tumor cells in early breast cancer under neoadjuvant therapy.

  2012cites this paper
• Disseminated and circulating tumour cells and their role in breast cancer.

  2012cites this paper
• Développement d' outils innovants pour le diagnostic et la découverte de cibles dans le cancer du sein

  2012cites this paper
• Sensitive Mesofluidic Immunosensor for Detection of Circulating Breast Cancer Cells onto Antibody-Coated Long Alkylsilane Self-Assembled Monolayers

  2012cites this paper
• Microfluidic, label-free enrichment of prostate cancer cells in blood based on acoustophoresis.

  2012cites this paper
• Surgery in metastatic breast cancer

  2012cites this paper
• Minimale Resterkrankung beim Magenkarzinom – eine Übersicht

  2011cites this paper
• The role of surgery in metastatic breast cancer.

  2011cites this paper
• Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications

  2011cites this paper
• Molecular mechanisms of metastasis

  2011cites this paper
• A mesofluidic multiplex immunosensor for detection of circulating cytokeratin-positive cells in the blood of breast cancer patients

  2011cites this paper
• [Minimal Residual Disease (MRD) in gastric carcinoma--an overview].

  2011cites this paper
• Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients

  2010cites this paper
• Development of mass spectrometry-based shotgun method for proteome analysis of 500 to 5000 cancer cells.

  2010cites this paper
• Circulating tumour cells in cancer patients: challenges and perspectives.

  2010cites this paper
• Marker-Free Isolation and Enrichment of Rare Cell Types Including Tumor Initiating Cells through Contactless Dielectrophoresis

  2010cites this paper
• Cytokeratin 19-positive circulating tumor cells in early breast cancer prognosis.

  2010cites this paper
• Impact of breast surgery on survival in patients with distant metastases at initial presentation: a systematic review of the literature

  2010cites this paper
• Insights into minimal residual disease in cancer patients: implications for anti-cancer therapies.

  2010cites this paper
• Emerging applications of fluorescent nanocrystals quantum dots for micrometastases detection

  2010cites this paper
• Circulating cancer cells.

  2010cites this paper
• Detection of circulating tumor Cells in the context of treatment: Prognostic value in breast cancer patients

  2009cites this paper
• Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT–PCR in patients with metastatic breast cancer

  2009cites this paper
• Cancer micrometastases

  2009cites this paper
• The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients

  2009cites this paper
• [Circulating tumor cells and breast cancer: detection techniques and clinical results].

  2009cites this paper
• Circulating tumor cells in breast cancer

  2008cites this paper
• Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance

  2008cites this paper
• Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients

  2008cites this paper
• Detection and characterization of disseminated tumor cells present in bone marrow of cancer patients

  2008cites this paper
• The direct molecular analysis of metastatic precursor cells in breast cancer: a chance for a better understanding of metastasis and for personalised medicine.

  2008cites this paper
• Circulating Tumor Cells and Bone Marrow Micrometastasis

  2008cites this paper
• Micrometastatic disease in breast cancer: clinical implications.

  2008cites this paper
• Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System

  2007cites this paper
• Surgery for palliation and treatment of advanced breast cancer.

  2007cites this paper
• Current status in human breast cancer micrometastasis

  2007cites this paper